Clients News • MC Services corporate website
paged,page-template-default,page,page-id-5522,paged-6,page-paged-6,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive




  • Newron AGM Result and Clinical and Business Update
  • Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD
  • Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy
  • Heidelberg Pharma AG: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
  • Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals’ LNA-modified ASOs to effectively block important immunosuppressive pathway
  • CENTOGENE AG: CENTOGENE startet Pilotprojekt zur Diagnose von unentdeckten Covid-19-Fällen
  • Secarna Pharmaceuticals announces the acquisition of LNAplusTM based antisense drug candidates by Lipigon Pharmaceuticals
  • Heidelberg Pharma AG: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update
  • Abivax 2019 Financial Results and Operations Update
  • dievini comments on press releases about CureVac